Bagalanon, Jessa Mae M.
HRN: 14-71-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2024
CEFUROXIME 750MG (VIAL)
08/23/2024
08/29/2024
IV
750 MG
Q8HRS
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes